Advertisement

Topics

Alnylam's gene silencing drug wins FDA approval

09:21 EDT 10 Aug 2018 | Reuters

Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology.

Original Article: Alnylam's gene silencing drug wins FDA approval

NEXT ARTICLE

More From BioPortfolio on "Alnylam's gene silencing drug wins FDA approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...